Publications

Biosimilar medicine fact sheet – infliximab

This fact sheet provides information about biosimilar brands of infliximab listed on the Pharmaceutical Benefits Scheme (PBS).

  • Inflectra® was listed on the PBS on 1 December 2015.
  • Renflexis® was listed on the PBS on 1 August 2017.

These brands are listed under the Section 100 Highly Specialised Drugs Program.

Biosimilar medicine fact sheet – infliximab

About this resource

Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Part of a collection:
Biosimilar medicines information collection
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.